In: PATENT NEWS
Teva’s ‘skinny label’ generic didn’t cause infringement of GSK’s patent, judge finds BioPharma Dive Teva won’t owe $235M penalty in Coreg ‘carve-out’ fight with GlaxoSmithKline FiercePharma Full coverage
In: PATENT NEWS
GAN’s Patent licensing program has made substantial progress in H2 2017 by placing diverse US casino operators on notice of GAN’s US-patented Intellectual property rights and inviting commercial licensing discussions which are ongoing. We remain highly confident in the significant strategic value to …
In: PATENT NEWS
14 Feb 2018 In order for an invention to be patentable it must be new as defined in the patent law, which provides that an invention cannot be patented if: “(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available... Continue reading
In: PATENT NEWS
Innovation Leaders: Cisco, Samsung, Intel Lead In IoT Patent Filings CRN Full coverage
In: PATENT NEWS
Biocept Obtains Patent for its Target Selector Molecular Biomarker Technology in China PR Newswire (press release) Full coverage
In: PATENT NEWS
Teva Skirts $235M Infringement Verdict In Coreg Patent Row Law360 Full coverage
In: PATENT NEWS
AI systems can simplify many complicated tasks. They can also complicate simple tasks, such as identifying who is the author, for intellectual property own.
In: PATENT NEWS
I am pleased to announce that Foley & Lardner has been recognized by IPWatchdog as one of the nation’s 10 most active patent firms based on the total number of U.S. utility patents that issued in 2017. The complete listing can be found here and features over 700 law firms.
In: PATENT NEWS
Strengthening the protection of intellectual property (IP) rights will help expand the market. To achieve this, India has been making continuous efforts to alleviate problems so that we can promote creativity, innovation and commercialisation of IP. A step taken by India in fulfilling this goal was the release …
In: PATENT NEWS
Join in-house counsel from major corporations and members of the judiciary, academia and private practice as they explore these issues at the tenth annual Symposium on Intellectual Property.
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION